No abstract available
MeSH terms
-
Adenocarcinoma / genetics*
-
Adenocarcinoma / pathology
-
Adenocarcinoma / surgery
-
Adenocarcinoma, Bronchiolo-Alveolar / genetics*
-
Adenocarcinoma, Bronchiolo-Alveolar / pathology
-
Adenomatous Polyposis Coli / genetics*
-
Adenomatous Polyposis Coli / pathology
-
Adenomatous Polyposis Coli / surgery
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Chemotherapy, Adjuvant
-
Colectomy
-
DNA Glycosylases / genetics*
-
Histiocytosis, Langerhans-Cell / genetics*
-
Humans
-
Lung Neoplasms / genetics*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy
-
Male
-
Mutation*
-
Neoadjuvant Therapy
-
Neoplasms, Multiple Primary*
-
Pelvic Neoplasms / genetics
-
Pelvic Neoplasms / therapy
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins p21(ras)
-
Radiotherapy, Adjuvant
-
Thyroid Neoplasms / genetics
-
Thyroid Neoplasms / therapy
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
ras Proteins / genetics
Substances
-
KRAS protein, human
-
Proto-Oncogene Proteins
-
DNA Glycosylases
-
mutY adenine glycosylase
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins